RituximabFailed to develop anti-SARS-Cov-2 antibodies: case report

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-021-06700-3
中图分类号
学科分类号
摘要
引用
收藏
页码:379 / 379
相关论文
共 50 条
  • [21] Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline
    Tuccori, Marco
    Ferraro, Sara
    Convertino, Irma
    Cappello, Emiliano
    Valdiserra, Giulia
    Blandizzi, Corrado
    Maggi, Fabrizio
    Focosi, Daniele
    [J]. MABS, 2020, 12 (01)
  • [22] Avidity assay to test functionality of anti-SARS-Cov-2 antibodies
    Gaspar, Emanuelle Baldo
    De Gaspari, Elizabeth
    [J]. VACCINE, 2021, 39 (10) : 1473 - 1475
  • [23] High seroprevalence of anti-SARS-CoV-2 antibodies in the capital of Chad
    Wondeu, Andrillene Laure Deutou
    Abdelrazakh, Fatima
    Abakar, Mahamat Fayiz
    Yandai, Fissou Henry
    Nodjikouambaye, Aleyo Zita
    Djimtoibaye, Djallaye
    Kimala, Pidou
    Nadjiadjim, Noel
    Naibei, Nathan
    Dzomo, Guy Rodrigue Takoudjou
    Atturo, Sabrina
    Linardos, Giulia
    Russo, Cristina
    Perno, Carlo Federico
    Moussa, Ali Mahamat
    Yokouide, Allarangar
    Tchidjou, Hyppolite Kuekou
    Colizzi, Vittorio
    Choua, Ouchemi
    [J]. JOURNAL OF PUBLIC HEALTH IN AFRICA, 2022, 13 (04)
  • [24] Duration of anti-SARS-CoV-2 antibodies much shorter in India
    Kumar, Nishant
    Bhartiya, Shibal
    Singh, Tarundeep
    [J]. VACCINE, 2021, 39 (06) : 886 - 888
  • [25] Case Report of COVID-19 after Full Vaccination: Viral Loads and Anti-SARS-CoV-2 Antibodies
    Komiazyk, Magdalena
    Walory, Jaroslaw
    Gawor, Jan
    Ksiazek, Iza
    Gromadka, Robert
    Baraniak, Anna
    [J]. DIAGNOSTICS, 2021, 11 (10)
  • [26] The Changing Use and Benefits of Anti-SARS-CoV-2 Monoclonal Antibodies
    Agarwal, Shanu
    File, Thomas M., Jr.
    [J]. INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2022, 30 (02)
  • [27] Case Report: Circulating Anti-SARS-CoV-2 Antibodies Do Not Cross-React With Pemphigus or Pemphigoid Autoantigens
    Kasperkiewicz, Michael
    Bednarek, Marta
    Tukaj, Stefan
    [J]. FRONTIERS IN MEDICINE, 2021, 8
  • [28] Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies
    Li, Ruofan
    Mor, Michael
    Ma, Bingting
    Clark, Alex E.
    Alter, Joel
    Werbner, Michal
    Lee, Jamie Casey
    Leibel, Sandra L.
    Carlin, Aaron F.
    Dessau, Moshe
    Gal-Tanamy, Meital
    Croker, Ben A.
    Xiang, Ye
    Freund, Natalia T.
    [J]. COMMUNICATIONS BIOLOGY, 2022, 5 (01)
  • [29] Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies
    Ruofan Li
    Michael Mor
    Bingting Ma
    Alex E. Clark
    Joel Alter
    Michal Werbner
    Jamie Casey Lee
    Sandra L. Leibel
    Aaron F. Carlin
    Moshe Dessau
    Meital Gal-Tanamy
    Ben A. Croker
    Ye Xiang
    Natalia T. Freund
    [J]. Communications Biology, 5
  • [30] Circulating anti-SARS-CoV-2 nucleocapsid (N)-protein antibodies and anti-SARS-CoV-2 spike (S)-protein antibodies in an African setting: herd immunity, not there yet!
    Nzoghe, Amandine Mveang
    Leboueny, Marielle
    Kamgaing, Eliane Kuissi
    Siawaya, Anicet Christel Maloupazoa
    Bongho, Eliode Cyrien
    Ndjindji, Ofilia Mvoundza
    Padzys, Guy-Stephan
    Ndeboko, Benedicte
    Ategbo, Simon
    Siawaya, Joel Fleury Djoba
    [J]. BMC RESEARCH NOTES, 2021, 14 (01)